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Objective: Although distinctive structural abnormalities occur in patients with
schizophrenia, detecting schizophrenia with magnetic resonance imaging (MRI) remains
challenging. This study aimed to detect schizophrenia in structural MRI data sets using a
trained deep learning algorithm.
Method: Five public MRI data sets (BrainGluSchi, COBRE, MCICShare, NMorphCH, and
NUSDAST) from schizophrenia patients and normal subjects, for a total of 873 structural
MRI data sets, were used to train a deep convolutional neural network.
Results: The deep learning algorithm trained with structural MR images detected
schizophrenia in randomly selected images with reliable performance (area under the
receiver operating characteristic curve [AUC] of 0.96). The algorithm could also identify
MR images from schizophrenia patients in a previously unencountered data set with an
AUC of 0.71 to 0.90. The deep learning algorithm’s classiﬁcation performance degraded
to an AUC of 0.71 when a new data set with younger patients and a shorter duration of
illness than the training data sets was presented. The brain region contributing the most to
the performance of the algorithm was the right temporal area, followed by the right parietal
area. Semitrained clinical specialists hardly discriminated schizophrenia patients from
healthy controls (AUC: 0.61) in the set of 100 randomly selected brain images.
Conclusions: The deep learning algorithm showed good performance in detecting
schizophrenia and identiﬁed relevant structural features from structural brain MRI data;
it had an acceptable classiﬁcation performance in a separate group of patients at an earlier
stage of the disease. Deep learning can be used to delineate the structural characteristics
of schizophrenia and to provide supplementary diagnostic information in clinical settings.
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Structural brain alterations in schizophrenia have been thoroughly
investigated with the development of neuroimaging methods
(1–3). Although there remain some controversies regarding the
use of antipsychotics and the duration of illness, a number of
studies have found overall gray matter loss (2), decreased volume
of the bilateral medial temporal areas (3) and a left superior
temporal region deﬁcit (1) in brains with schizophrenia. As these
structural abnormalities are thought to be linked to the positive
symptoms of schizophrenia (4, 5), it has been suggested that the
neuropathology and etiology of schizophrenia might be related to
alterations in brain structure (6).
Although studies on volumetric magnetic resonance imaging
(MRI) analysis in schizophrenia have shown relatively consistent
results over several decades (7), diagnosing schizophrenia
based on these ﬁndings is still challenging and has little clinical
utility. One possible reason is that the predictive value of
biological features of schizophrenia weakens in real-world
patients who have symptoms superﬁcially resembling those
of other psychiatric illnesses (8). Multiple internal phenotypes
of schizophrenia, such as electrophysiological properties (P50,
P300, and mismatch negativity), achieved a high diagnostic
accuracy of approximately 80%, but these features were
studied in relation to genetic analysis rather than clinical
application (9). Another reason is that certain cortical features
found in schizophrenia are shared with other neurodegenerative
diseases; thus, the patient’s clinical history of psychiatric
problems is needed to discriminate these mental illnesses (10).
Recent machine learning methods continue to address these
issues. As deep learning algorithms have achieved superior
performance in visual image recognition (11), their clinical
signiﬁcance has increased in certain diagnostic tasks, such as
detecting pulmonary nodules on chest CT scans (12) and
diagnosing diabetic retinopathy from retinal fundus photographs
(13). Similar studies have been conducted in schizophrenia
patients using structural MRI data, and acceptable accuracy
rates have been achieved (68.1% to 85.0%) (14–17). A deep
belief network achieved a higher accuracy rate than a classical
machine learning algorithm in discriminating schizophrenia
patients from healthy controls (15). One of the important
characteristics of deep learning is that it learns through labeled
images and identiﬁes important features without explicitly
designated characteristics (11, 18), and it learns representations
of input data as the information ﬂow ascends through multiple
layers (11). Therefore, in order to infer the cortical features of
schizophrenia using deep learning algorithms, it is necessary to
examine how such a decision is made and compare those ﬁndings
with the results of volumetric MRI studies.
In this study, we trained a deep learning algorithm (19)
to identify schizophrenia using ﬁve multicenter data sets
of structural MRI results and assessed the classiﬁcation
performance of the algorithm in a single-center, clinical
validation set. Furthermore, we examined which brain regions
mainly contributed to the decisional process of the deep
learning algorithm.Frontiers in Psychiatry | www.frontiersin.org 2METHODS
Data Sets
Publicly available neuroimaging data from schizophrenia
patients and normal subjects were obtained from the
SchizConnect (https://www.schizconnect.org) database (20).
Among 1,392 sets of data from subjects in this database, we
used 873 sets of structural MRI information available from 5
multicenter data sets, i.e., BrainGluSchi (21), COBRE (22),
MCICShare (23), NMorphCH (24) and NUSDAST (25). These
data sets had been acquired to investigate the brain metabolism
of patients with schizophrenia (BrainGluSchi) and included both
structural and functional images (COBRE and MCICShare). The
structural images were obtained from 1998 to 2016, and the
scanner ﬁeld strength varied among data sets (1.5 T and 3 T,
Table 1). All raw images were evaluated by the authors of the
present study, and images not applicable for training the deep
learning algorithm (e.g., those with excessive motion or noise or
an image error) were excluded (Table 1). The study protocol was
approved by the Institutional Review Board of Seoul St. Mary’s
Hospital (KC18ZESI0615).
Among a total of 873 raw images (449 of patients with
schizophrenia, 424 of normal subjects), seven images with
excessive motion and noise were excluded (Figure 1). Thus,
866 eligible images (443 of patients with schizophrenia, 423 of
normal subjects) were used to train the deep learning model
(Table 1). All MRI data were acquired by high-resolution T1-
weighted structural magnetization-prepared rapid gradient-echo
(MPRAGE) scans, but the scanning parameters varied across
data sets (Supplementary Table 1).
Among 449 data sets from schizophrenia patients in the
training data set, 181 were categorized as the “schizophrenia
(broad)” group, and 240 were categorized as the “schizophrenia
(strict)” group. Schizophrenia (broad) refers to the diagnosis of
both schizophrenia and schizoaffective disorder (20), although
this distinction was not included in the clinical diagnosis. We
included the data of the schizophrenia (broad) group in the
analysis because these two diseases may share similar
characteristics and disease courses (26) and have usually been
included together in imaging studies (27).
The validation data set was acquired in a single center
in South Korea and consisted of data from 30 patients
with schizophrenia and 30 healthy controls (Table 1). As
this data set had detailed information on each subject, we
could evaluate the severity of disease, duration of treatment,
and use of antipsychotics. The patients in this data set
were “mildly ill” and had “some mild symptoms” in their
lives, as assessed by the Positive and Negative Symptom
Scale (PANSS) (28) and Global Assessment of Functioning
(GAF) (29), respectively. This data set also had some
demographic differences from the 5 multicenter data sets
from the SchizConnect database; in particular, the validation
data set included relatively younger subjects (mean [SD]:
SchizConnect = 35.3 [12.6], Uijeongbu St. Mary’s = 31.9 [7.2])
and had a higher proportion of females (ratio of females;
SchizConnect = 23.4%, Uijeongbu St. Mary’s = 58.3%).February 2020 | Volume 11 | Article 16
Oh et al. Identifying Schizophrenia With MR ImagesThese features of the validation set enabled us to verify whether
the trained deep learning model could ﬂexibly cope with a new
situation, i.e., a data set with different disease characteristics than
the training data sets.Frontiers in Psychiatry | www.frontiersin.org 3Image Preprocessing
All Nifti images were manually evaluated by the authors using
MRIcron software (http://www.cabiatl.com/mricro/mricron/
index.html). The slice number on the z-axis that correspondedTABLE 1 | Sample characteristics of 5 public schizophrenia MRI and validation data sets.
Characteristics BrainGluSchi COBRE MCICShare NMorph NUSDAST Validation data set
No. of images 175 184 204 90 220 60
No. of normal images 89 94 95 44 102 30
No. of schizophrenia images 86 90 109 46 118 30
Patient demographics 　 　 　 　 　 　
Age, mean (SD), years 36.7 (14.2) 38.3 (12.6) 33.9 (11.6) 31.9 (7.8) 32.9 (12.0) 31.9 (7.2)
Age, range (min/max) 16/65 18/66 18/61 19/46 14/66 22/50
Female, No./total (%) 36 / 175 (20.6) 45 / 184 (24.5) 56 / 190 (29.5) 36 / 90 (40.0) 84 / 218 (38.5) 35 / 60 (58.3)
Image quality 　 　 　 　 　 　
Acquisition year 2010 to 2013 2009 to 2013 2004 to 2006 2008 to 2013 1998 to 2006 2014 to 2016
Scanner ﬁeld strength 3 T 3 T 1.5 T/3 T 3 T 1.5 T 1.5 T
No. with excessive motion – – – 2 – –
No. with excessive noise – 1 1 – 1 –
No. with image errors – – – – 2 –
Psychiatric diagnosis 　 　 　 　 　 　
Schizophrenia (broad)
a
86 – 95 – – –
Schizophrenia (strict) – 79 – 44 117 30
　 Schizoaffective disorder – 11 – 2 – –
Disease characteristics
b
　 　 　 　 　 　
Duration of illness (SD), year – N/A 10.67 (10.3) N/A – 4.89 (3.47)
Duration of treatment (SD), month – – – 14.7 (18.8)
Antipsychotic use (%) 93.3 – – 100.0
PANSS (SD)
c
– – – 54.9 (28.4)
SAPS (SD)
d
– 4.96 (2.77) 11.1 (12.7) –
SANS (SD)
e
– 8.00 (3.91) 9.6 (10.7) –
　 GAF score (SD)
f
– – – 62.8 (12.3)February 2020 | VoaIncludes both schizophrenia and schizoaffective disorder.
bDisease characteristics of public data sets represent whole patients of each study.
cPositive and Negative Syndrome Scale.
dScale for the Assessment of Positive Symptoms.
eScale for the Assessment of Negative Symptoms.
fGlobal Assessment of Functioning.FIGURE 1 | Five public MRI data sets for the detection of schizophrenia through a deep learning algorithm. (A) Normal data sets consisted of structural MR images
obtained from healthy control subjects. (B) Schizophrenia data sets consisted of structural MR images obtained from schizophrenia and schizoaffective disorder patients.lume 11 | Article 16
Oh et al. Identifying Schizophrenia With MR Imagesto the top of the skull and the x-y coordinates of the midbrain
were measured on the coronal view of each image. Then, each
slice of the transverse section was converted to a frame, and these
frames were combined into a video (Supplementary Figure 1
and Supplementary Video 1) using MATLAB software
(MathWorks, Inc., MA). The image intensity of each video was
normalized within the data set (i.e., the mean image intensity was
equalized between MR images of normal subjects and patients
with schizophrenia) to prevent the algorithm from classifying
diseases based on the basic properties of images.
We used a series of videos rather than the entire 3D Nifti
image as the input for the following reasons. First, we aimed to
reproduce the way clinicians actually read brain MR images.
Clinicians do not interpret the MR images as a whole but
examine the pre-post slices in a serial process. As deep
learning essentially imitates the structure of the human cortex
and the information processing of the brain (30), we decided that
the inputs provided to the deep learning algorithm should be
similar to those that humans would actually experience (31).
Development of The Algorithm
A three-dimensional convolutional neural network (3DCNN)
architecture was used for classifying patients with schizophrenia
and normal subjects based on the structural MRI data sets (32–
34); the original 3DCNN architecture was developed for video
classiﬁcation (https://github.com/kcct-fujimotolab/3DCNN).
The input to the 3DCNN was a converted video of a subject’s
structural MR images (concatenated slices along the z-axis;
Supplementary Figure 1). The input dimensions were 256 ×
256 × 180. This architecture has four 3D convolutional layers,
with max-pooling-based downsampling in each convolutional
layer. A previous study using the ADNI data set showed that
3DCNNs with only one convolutional layer outperformed other
classiﬁers in predicting the Alzheimer’s disease status of a patient
based on an MRI scan of the brain (35). More recently, four
3DCNNs were used in high-precision segmentation and
classiﬁcation problems, reportedly achieving state-of-the-art
performance (36, 37). We applied a rectiﬁed linear unit
(ReLU) activation function, which is the most commonly used
activation function in deep learning models. The function
returns 0 if it receives any negative input, but for any positive
value x, it returns the input value, as follows: f(x) = max(0, x).
This activation function is known to effectively capture the
interactions and nonlinearities of data sets (11, 38).
The kernel size was 3 × 3 × 3, and the pooling size was the
same. The kernel size was selected to match the Gaussian kernel
size used for MRI postprocessing to reduce artifacts (39). We
applied the parameters of depth = 15 and color = true settings, so
that the ﬁrst layer was 32 × 32 × 15 × 3. The original input had 11
million parameters (256 × 256 × 180 = 11,796,480), and it was
downsampled to 30,720 parameters (32 × 32 × 15 × 3). Thus,
there was 384× parameter reduction (11,796,480/30,720=384).
The ReLU activation function and a dropout rate of 0.25 were
used for each convolutional layer. At the end of the convolutional
layers, one densely connected layer with a dropout rate of 0.5 was
attached. The models were trained for 50 epochs with a batch size
of 32 (40). The training was stopped as soon as convergence wasFrontiers in Psychiatry | www.frontiersin.org 4achieved (epochs = 50, Supplementary Figure 4) to avoid
unexpected overﬁtting that could confound the results.
Previous studies have shown that stopping the training process
early could potentially improve the generalization (41, 42). The
learning rate and momentum for stochastic gradient descent
(SGD) were set to 0.001 and 0.9, respectively. All trainings and
experiments were run on a standard workstation (64 GB RAM,
3.30 GHz Intel Core i7 CPU, NVidia GTX 1080, 8 GB VRAM).
Model training ran for ~30 hours. A full model of the deep
learning algorithm is presented in Supplementary Figure 2, and
the algorithms used in this study have been uploaded to a
developer community and can be freely downloaded (https://
github.com/yunks128/3D-convolutional-neural-networks).
Evaluating Algorithms Using The Training
and Validation Data Sets
To avoid the overﬁtting problem (43), we applied 10-fold cross-
validation in training the deep learning algorithm (44). The
original data set was randomly partitioned into 10 equally sized
data subsets, and a single data subset was used as the validation
set for testing the model trained with the other data subsets
(Figure 2A). We also applied cross-validation to each of the ﬁve
data sets individually; one of the ﬁve data sets was designated as a
test set, and the remaining four were used for training. In this
validation, the deep learning model was trained with four of ﬁve
data sets, and a remaining data set was used as a test set. For
example, the deep learning model trained with the COBRE,
MCICShare, NUSDAST, and NMorph data sets was assessed for
the ability to identify schizophrenia in the BrainGluSchi data set.
This method enabled us to evaluate whether the trained deep
learning algorithm could classify structural images obtained
from schizophrenia patients with different scanning parameters
and scanner ﬁeld strengths (Figure 2B).
To determine whether the trained deep learning algorithm
could distinguish patients with schizophrenia from healthy
controls in real-world MRI data sets, we used a new data set
obtained by Uijeongbu St. Mary’s Hospital in South Korea. This
data set consisted of structural MRI data from 30 schizophrenia
patients and 30 healthy controls (Table 1).
Regional Analysis
To determine which brain regions contributed most to the
classiﬁcation, we divided the transverse section of the MR
image into eight regions (Figure 3A). Based on the x-y
coordinates of the midbrain, a black circle with a radius of 30
pixels was drawn in each frame. Then, a black triangle with end
points at the center of the circle and at a vertex and midpoint of
the image was drawn in every frame. We made a total of eight
different videos in which the triangle occluded eight different
regions (Figure 3B and Supplementary Video 2). Transverse
brain sections with one of the eight areas occluded were used to
train the deep learning algorithm. Then, we evaluated how the
performance of the deep learning algorithm changed in
distinguishing patients with schizophrenia from healthy
controls. If the area under the receiver operating characteristic
curve (AUC) and accuracy rate signiﬁcantly dropped, we could
infer that the structural MRI information in that area mainlyFebruary 2020 | Volume 11 | Article 16
Oh et al. Identifying Schizophrenia With MR ImagesFIGURE 2 | Performance in detecting schizophrenia in ﬁve public MRI data sets. Performance in identifying schizophrenia in ﬁve publicly available MRI data sets.
(A) The deep learning algorithm was trained with 693 randomly selected images (80% of all images) and discriminated between patients with schizophrenia and
normal subjects in the remaining 173 MR images. This process was repeated 10 times (10-fold cross-validation). The area under the receiver operating characteristic
(ROC) curve (AUC) was 0.959. The red and purple circles on the graph represent optimal operating points; the sensitivity was 96% and the speciﬁcity was 96% at
these points, respectively. The gray diamond represents the optimal operating point, which had 92% sensitivity and 85% speciﬁcity. (B) Validation of algorithm
performance across the data sets. The deep learning algorithm was trained with MR images from four of ﬁve data sets, and the remaining one data set was used as
a validation set. The algorithm trained without the MCICShare data set showed the highest performance (red line, AUC of 0.902), and the algorithm trained without
the BrainGluSchi data set showed the lowest performance (blue line, AUC of 0.710).FIGURE 3 | Analysis of contributing brain regions for detecting schizophrenia. Contribution of each brain region in identifying MR images from patients with
schizophrenia. Each MR transverse slice was divided into eight regions, and one of these regions was occluded with a black triangle. Thus, no information was
provided from this portion of the brain. The deep learning algorithm was trained with these handicapped inputs and subsequently used to classify MR images.
(A) Schematic diagram of eight arbitrarily determined brain regions. The center of the circle corresponds to the center of the midbrain, and the endpoint of each line
corresponds to a vertex and midpoint of the image. (B) A sample slice that was used as an input to the algorithm. Areas corresponding to ventricles and region 1
are covered. (C) Performance of the deep learning algorithm. Region 1 mostly contributed to identifying schizophrenia, as the performance dropped to an AUC of
0.58 when the information from region 1 was not provided.Frontiers in Psychiatry | www.frontiersin.org February 2020 | Volume 11 | Article 165
Oh et al. Identifying Schizophrenia With MR Imagescontributed to identifying schizophrenia. This method is more
arbitrary than using the parcellation of cortical areas from 3D
Nifti images (45), but it is advantageous in that it reduces the
processing time and resources needed to analyze a large amount
of MRI data.
Logistic Regression Algorithm
For Validation
Although we normalized the mean intensity of all MR images,
one may argue that simple MRI intensity differences between the
schizophrenia and normal groups may provide signiﬁcant
classiﬁcation power. To test whether information on mean
intensity could be used to determine whether a given subject
has schizophrenia, we independently applied the logistic
regression classiﬁer. The method estimates the log odds of an
event that can be mathematically expressed as a multiple linear
regression function. Let the predictor X1 be the mean image
intensity, and let the binary response variable Y be the output of
either schizophrenia or normal, where the probability of Y is
denoted as p = P(Y=1). The log odds, L, can be written as follows
(where B0 and B1 are parameters of the model):
L = log
p
1 − p
 
= B0 + B1X1
Clinician Rating Experiments
To investigate whether clinicians could identify the imaging
characteristics of schizophrenia, we presented one hundred
randomly selected videos (50 from schizophrenia patients and
50 from normal subjects) to seven clinicians (ﬁve psychiatrists
and two radiologists). The clinicians were required to rate the
likelihood that the presented video was from a schizophrenia
patient as a number from 0 to 100. Before the rating, they were
told the main characteristics of the brain of patients with
schizophrenia but were naïve to diagnosing schizophrenia
based on brain MRI data. To determine whether there is a
learning effect in the classiﬁcation performance of humans, the
same psychiatrist performed 3 consecutive experiments. After
each session, he/she was provided with the correct answers. Each
session consisted of 100 randomly selected videos, which were
completely different in each session.RESULTS
In the training data set, the deep learning model achieved high
performance in classifying the structural MRI data of
schizophrenia vs. normal subjects (AUC of 0.96, Figure 2A).
The overall accuracy rate was 97%, meaning that among 866
images, 840 images were classiﬁed correctly. The probability of
randomly selected images being classiﬁed as schizophrenia by
chance was 51.2% (443 schizophrenia and 423 normal images).
The sensitivity of the algorithm at the high-sensitivity operating
point was 96%, and the speciﬁcity at the high-speciﬁcity operating
point was 96%. The sensitivity and speciﬁcity at the optimal
operating point was 92% and 85%, respectively (gray diamondFrontiers in Psychiatry | www.frontiersin.org 6in Figure 2A). The mean image intensity (range, 0 to 255) across
all images in the schizophrenia group was 52.52 (SD = 23.68), and
that in the normal group was 50.40 (SD = 22.57). The logistic
regression machine learning algorithm failed to classify
schizophrenia and normal subjects (accuracy rate = 51.2%,
chance level = 51.1%) in these data sets; thus, image quality and
intensity did not affect the classiﬁcation performance.
To test the performance of the algorithm across each training
data set, we further evaluated the classiﬁcation performance
using a separate data set as the test set (Figure 2B). Deep
learning achieved the highest classiﬁcation performance when
the MCICShare data set was presented as a new input (AUC of
0.90) and showed the lowest performance in classifying the
BrainGluSchi data set (AUC of 0.71). These results suggest that
the data sets contributed unequally to classifying the
characteristics of schizophrenia; the BrainGluSchi data set
might contain crucial information for distinguishing patients
with schizophrenia from normal subjects.
The performance of the deep learning algorithm that
identiﬁed patients with schizophrenia was somewhat lowered
in a completely new data set (Uijeongbu St. Mary’s). When the
deep learning algorithm had a new input from the validation set
consisting of 60 structural images that had slightly different
disease characteristics relative to the training sets, its predictive
AUC value dropped from 0.95 to 0.72 (Figure 4A). The accuracy
rate of the deep learning algorithm in the validation data set was
70.0%, compared to a 50% chance level. This ﬁnding shows that
the predictive power of the deep learning algorithm signiﬁcantly
decreased when it encountered MRI information completely
different from the data used for training.
To investigate whether the spatial information of an individual
MRI data set affects the classiﬁcation ability of the deep learning
algorithm, we further analyzed the regional data. Figure 3
summarizes the process and the results of this analysis. Among
the eight occluded areas, when the area marked by 1 (roughly
corresponding to the right temporal region) was colored black
with zero image intensity, the AUC dropped from 0.96 to 0.57,
which was the largest change. In contrast, when the area marked
by 3 was occluded, the change in the AUC was smaller (0.96 to
0.89); this area contained the right frontal region.
Although clinicians rarely diagnose schizophrenia based on
structural MRI alone, we tested whether experts in related ﬁelds
can distinguish between MR images from patients with
schizophrenia and normal subjects. Seven clinical specialists,
ﬁve psychiatrists and two radiologists, were brieﬂy told the
known ﬁndings of brain abnormalities in schizophrenia and
were given 100 randomly selected videos (50 of patients with
schizophrenia, 50 of normal subjects) that were identical to those
used in training the deep learning algorithm. The overall
accuracy rate of the seven specialists was 62% (AUC of 0.61),
which was barely over the chance level (50%) (Figure 4B and
Supplementary Table 2). The sensitivity and speciﬁcity at the
optimal operating point was 81.6% and 47.1%, respectively. The
test for a learning effect in the psychiatrist showed that there was
no improvement in the AUC as the sessions proceeded
(Supplementary Figure 3).February 2020 | Volume 11 | Article 16
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Our results imply that a deep learning algorithm trained
with large structural MRI data sets could discriminate patients
with schizophrenia from healthy participants. Without any
explicit instructions or lesion-related information, deep neural
networks can learn and ﬁnd relevant brain regions that
mainly contribute to the identiﬁcation of scans from patients
with schizophrenia. Interestingly, the brain regions that most
affected the deep learning algorithm (the right temporal and
right temporoparietal areas) corresponded to previous ﬁndings
of voxel-based analyses.
Although our results are still incomplete regarding
application for the clinical diagnosis of schizophrenia, they
have several advantages. The deep neural network trained with
structural MRI data sets achieved high sensitivity and speciﬁcity
(96% and 96%, respectively), higher than those obtained in
previous studies that used other machine learning algorithms
(accuracy rate of 85.0%) (14) and similar deep belief networks
(AUC of 0.79) (15). This improvement in classiﬁcation
performance might have been related to the number of images
in our study being larger than that in the previous study (143
patients in the study by Pinaya et al. (15) vs. 443 patients in this
study), as the performance of deep learning improves when more
data become available (46).
The classiﬁcation performance was relatively acceptable in the
ﬁve multicenter data sets provided by the SchizConnect database,
but the performance degraded in the data set from the single
center acquired in South Korea (accuracy rate of 70.0% and AUC
of 0.72). Because the trained deep learning algorithm had
consistently shown high performance even in data sets with
different scanning parameters and scanner ﬁeld strengths (e.g.,Frontiers in Psychiatry | www.frontiersin.org 7identifying schizophrenia in the COBRE data set with algorithms
trained on the other 4 multicenter data sets, Figure 2B), these
results do not ensure that the predictive ability of trained deep
learning algorithms is limited. Rather, the change in performance
might be related to the different disease characteristics in the
patients included in the data sets. In the MCICShare data set, the
illness duration of the patients with schizophrenia was 10.67 (SD =
10.03) years (23), but patients in the validation data set from
Uijeongbu St. Mary’s hospital had an average illness duration of
4.89 (3.47) years. The age range of patients in the validation set
was smaller (22 to 50) than that in the training data sets (16 to 66)
(Table 1). Thus, it can be inferred that the schizophrenia patients
in the validation data set were younger and had less advanced
disease than those in the training set. As there are progressive
morphometric changes in the brain of a schizophrenia patient over
time (47), structural abnormalities in the validation data set could
have been somewhat smaller than those in the training data sets.
These substantial differences in participant characteristics between
the training and validation data sets might degrade the
classiﬁcation ability of the deep learning algorithm.
Regional analysis showed that different brain regions
contributed unequally to identifying schizophrenia (Figure 3).
The area that includes the right temporal region (marked as #1)
contributed the most to discriminating between scans from
patients with schizophrenia and normal subjects, followed by
the right temporoparietal (marked as #2) and left frontal
(marked as #4) regions. Information from the left occipital
(marked as #7) and right frontal (marked as #3) areas made
small contributions, as the AUC was largely preserved (> 0.86)
when these regions were treated as “null.” These results
correspond to the ﬁndings of voxel-based meta-analyses of
brain images from subjects with schizophrenia (2, 3, 48).FIGURE 4 | Validation of the algorithm using a different data set and the performance of clinical specialists. (A) The algorithm trained with ﬁve public data sets
discriminated scans from patients with schizophrenia and normal subjects in the validation data set, which consisted of patients who were younger and at an earlier
stage of the disease. (B) Classiﬁcation performance of clinical specialists who had been semitrained regarding the structural characteristics of the brain in
schizophrenia. The black diamond highlights the optimal operating point of all humans (sensitivity = 81.6%, speciﬁcity = 47.1%), and each colored circle shows the
optimal operating point of each individual.February 2020 | Volume 11 | Article 16
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schizophrenia patients, especially in the medial temporal lobe
(74% of studies reviewed), and 100% of reviewed studies reported
abnormalities in the superior temporal gyrus (48). However,
there was moderate evidence of abnormalities in the frontal and
parietal lobes, as approximately 60% of the reviewed studies
reported ﬁndings to that effect (48).
In this study, the deep learning algorithm was informed of only
the label of each input video (“schizophrenia” or “normal”), and
no other explicit instructions were given. Thus, the deep learning
algorithm identiﬁed certain brain characteristics of schizophrenia
on its own during the training and used this information to classify
brain MR images. Although we used qualitative methods rather
than precise cortical parcellation to divide brain regions (49), these
results suggest that a deep learning algorithm could be used to
identify certain brain features of schizophrenia, complementing
the ﬁndings of previous studies.
Identifying schizophrenia using structural MR images is
uncommon in clinical settings. The diagnosis of schizophrenia
mainly depends on the psychiatrist’s detailed interview with
patients and his/her family and the use of systematic
diagnostic tools (29). The relatively low performance of the
clinicians in this study may have been because they were not at
all familiar with identifying the disease through MR images.
Although clinical specialists were made aware of several cortical
features of the brain in schizophrenia, they were not equally
skilled competitors with the deep learning algorithm. The format
of the videos, in which pre-post slices could not be freely
investigated (which is possible in the PACS framework), could
have also contributed to the difﬁculty experienced by clinicians in
identifying certain features of schizophrenia. Thus, the poor
classiﬁcation rate of these seven clinical specialists would not
be interpreted to suggest the superiority of deep learning or
machine learning algorithms to humans in identifying
schizophrenia based on structural MRI data sets. Recent
studies in other medical ﬁelds have compared humans and
machine learning algorithms (50) and suggested that for the
best performance of artiﬁcial intelligence, augmenting human
intelligence is necessary (51).
There are several limitations to this study. All MRI data used
in training the deep learning algorithm had binary labels
(schizophrenia or normal). This dichotomous classiﬁcation is
widely used in studies of artiﬁcial intelligence, but it can be a
barrier to applying this system in clinical practice. Most
psychiatric diseases develop over a continuous spectrum (52),
and multiple illnesses can coexist in a patient. As our analysis did
not include a clinical comparison group, further study including
other psychiatric illnesses, such as bipolar spectrum and
neurodegenerative disorders, is needed. Because of this lack of
clinical control groups, it is difﬁcult to infer that the observed
features of schizophrenia (i.e., medial temporal lobe
abnormalities) are distinctive to schizophrenia.
Furthermore, within the data sets, there was no speciﬁc
information regarding details of the illness (e.g., the presence
of positive and negative symptoms of schizophrenia or theFrontiers in Psychiatry | www.frontiersin.org 8number of episodes). Thus, it was unclear whether the trained
deep learning algorithm could discriminate progressive
morphological changes in the patients with schizophrenia from
the features of healthy controls.
Another crucial limitation is whether schizophrenia can be
diagnosed solely by structural features of the brain. Unlike other
diseases that can be accurately detected by photographs (13),
schizophrenia is a disease accompanied by both structural and
functional abnormalities. Recent studies have shown that
functional MRI data and artiﬁcial intelligence techniques can
also be used to reliably identify schizophrenia (53); thus,
combining structural and functional features of brain images
would be expected to increase the potential for clinical usage.
Another limitation is that the region of interest was not speciﬁed
in our regional analysis, in which one of eight regions in
transverse sections was roughly occluded. A more detailed
cortical parcellation might be required to accurately match the
regions that contributed the most to deep learning with regions
identiﬁed in previous studies using voxel-based analyses. The
inconsistent data quality within the data set is another limitation.
For example, the MCICShare and NUSDAST data sets had MRI
data collected using a 1.5 T scanner, which has a lower signal-to-
noise ratio and image resolution than data collected using a 3 T
scanner. This low-image-quality data set could have obscured
the performance of the algorithm. Finally, we should note that
the results obtained from seven clinicians do not imply that the
ability of humans to identify schizophrenia from MR images
is decreased compared to that of deep learning algorithms.
Cautious interpretation of the results is needed because the
clinical specialists in this study were not experts in diagnosing
psychiatric illnesses through MR images.CONCLUSIONS
Deep neural networks trained with multicenter structural MRI
data sets showed high sensitivity and speciﬁcity in identifying
schizophrenia. The developed deep learning algorithms
identiﬁed schizophrenia fairly well in a new MRI data set
acquired by a single center in which the disease characteristics
of the patients were somewhat different. The deep learning
algorithm depended mainly on information from the right
temporal area in classifying schizophrenia. Deep learning
algorithms trained with large data sets consisting of various
stages and severities of illnesses could help clinicians
discriminate schizophrenia from other psychiatric diseases and
delineate the particular structural and functional characteristics
of the brain in patients with schizophrenia.DATA AVAILABILITY STATEMENT
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